<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="121309">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01523496</url>
  </required_header>
  <id_info>
    <org_study_id>09-11-06</org_study_id>
    <nct_id>NCT01523496</nct_id>
  </id_info>
  <brief_title>Vitamin D Supplementation in HIV Youth</brief_title>
  <official_title>Vitamin D Supplementation and HIV-related Complications in Children and Young Adults</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emory University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the correct dose of Vitamin D to give to prevent
      HIV related complications.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2011</start_date>
  <completion_date type="Actual">August 2016</completion_date>
  <primary_completion_date type="Actual">August 2016</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Participant, Care Provider, Investigator, Outcomes Assessor</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitamin D levels</measure>
    <time_frame>24 months</time_frame>
    <description>Evaluate the dose-related efficacy of correction of Vitamin D deficiency for improving 25(OH)D levels in a group of HIV-infected children and young adults and a matched healthy control group in a randomized controlled study of 3 different dosing regimens of oral Vitamin D supplementation.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Impact of Vitamin D levels on surrogate markers of CVD</measure>
    <time_frame>6, 12 and 24 months</time_frame>
    <description>Evaluate the dose-related efficacy of correction of vitamin D deficiency for improving surrogate markers (Pulse wave velocity, Carotid IMT)of CVD in a group of HIV-infected children and young adults and a matched healthy control group in a randomized controlled study of 3 different dosing regimens of oral vitamin D supplementation.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">295</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>HIV + Young Adults</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>All will be HIV+ and receiving randomized dose of vitamin D3</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV - Controls</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>HIV negative controls randomized to one of 3 doses of Vitamin D3</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>Vitamin D3, randomized to receive either 18,000 IU per month, 60,000 IU per month or 120,000 IU per month</description>
    <arm_group_label>HIV + Young Adults</arm_group_label>
    <arm_group_label>HIV - Controls</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin D3</intervention_name>
    <description>Vitamin D3 18,000IU/month; 60,000IU/month; 120,000IU/month</description>
    <arm_group_label>HIV + Young Adults</arm_group_label>
    <arm_group_label>HIV - Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ages 8-25

          -  Documented HIV-1 infection

          -  On stable ART for &gt; 3 months

          -  Cumulative ART of at least 6 months

          -  25(OH)D level &lt; 30 ng/ml at screening

        Exclusion Criteria:

          -  &gt; 400 IU daily regular vitamin D intake

          -  Parathyroid/calcium disorders

          -  Active malignancy

          -  Pregnancy/intent to become pregnant/breastfeeding

          -  Chronic infectious/inflammatory conditions

          -  Creatinine clearance &lt; 50 ml/min

          -  Hemoglobin &lt; 9.0 g/dL

          -  AST and ALT &gt; 2.5 ULN

          -  Diabetes requiring hypoglycemic agents

          -  Known coronary artery disease

          -  Inability to swallow pills
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Grace McComsey, MD, FIDSA</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Cleveland Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emory Children's Center</name>
      <address>
        <city>Atlanta</city>
        <state>Georgia</state>
        <zip>30322</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 9, 2017</lastchanged_date>
  <firstreceived_date>January 27, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospitals Cleveland Medical Center</investigator_affiliation>
    <investigator_full_name>Grace McComsey</investigator_full_name>
    <investigator_title>Professor of Pediatrics and Medicine, Chief Pediatric Infectious Diseases, Rheumatology and Global Health</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Vitamin D Deficiency</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
